Neoadj. Atezolizumab + CRT vs. concurrent with CRT for LACC: Randomized phase I trial NRG-GY017 shows expanded TCR clones. High-risk insights! #CervicalCancerStudy PMID:39788967, Nat Commun 2025, @NatureComms
#CervicalCancerStudy